CLINICAL_TRIALS
trial_result
· 2013-11-04
Clinical Trial Update: An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica [Phase 1, Phase 2]
Summary
An open-label Phase 1/2 trial evaluating eculizumab in neuromyelitis optica (Devic's disease) has completed, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Neuromyelitis Optica, Devic's Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-11-04